S055 Consultative Dermatology for the Hospitalized Patient
DESCRIPTION
In this high-yield session, expert Dermatology Hospitalists will review some of the most common skin diseases seen in consultation. Topics include: pediatric emergencies, oncodermatology, severe cutaneous adverse reactions, vasculitis, bullous diseases, and more. Information will be delivered in high-impact 20-minute specialty segments with an emphasis on practical practice points that are not necessarily available in the literature or textbooks. The ultimate goal of this session is to equip attendees with practical and immediately applicable skills for inpatient and consult work within the house of medicine.
LEARNING OBJECTIVES
Identify cutaneous manifestations of systemic diseases, medication reactions, and infections as they present in the hospitalized patient with skin disease.
Develop a working differential diagnosis, management plan, and treatment algorithm for hospitalized patients with skin disease.
Apply a host of new tips and tricks for performing bedside diagnostics, obtaining samples and performing procedures.
SCHEDULE
9:00 AM
Unpacking the Inpatient Consultant's Bag of Tricks: Essential Tips and Pearls for Bedside Diagnostics and Procedures
Helena Pasieka, MD, FAAD
9:30 AM
Inpatient Oncodermatology: Considerations for the Hospitalized Cancer Patient
Steven T. Chen, MD, MPH, FAAD
10:00 AM
Differentiating SCARS and Other Morbilliform Eruptions
Benjamin Kaffenberger, MD, FAAD
10:30 AM
A Practical Approach to Vasculitis
Robert Micheletti, MD, FAAD
11:00 AM
Little Ones, Large Lessons: Essentials of Pediatric Dermatology Consults
Kalyani Marathe, MD, MPH, FAAD
11:30 AM
Leg Ulcers Unwrapped: A Practical Approach
Jesse J Keller, MD, FAAD
DIRECTOR
Helena Pasieka, MD, FAAD
SPEAKERS
Steven T. Chen, MD, MPH, FAAD
Benjamin Kaffenberger, MD, FAAD
Jesse J Keller, MD, FAAD
Kalyani Marathe, MD, MPH, FAAD
Robert Micheletti, MD, FAAD
HANDOUTS
DISCLOSURES
Steven T. Chen, MD, MPH, FAAD
AbbVie – Advisory Board(Honoraria); Vertex Pharmaceuticals Incorporated – Employee (w-2 relationship)(Salary); VisualDx – Independent Contractor(Fees);
Benjamin Kaffenberger, MD, FAAD
Almirall – Consultant (1099 relationship)(Honoraria); Boehringer Ingelheim – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Dermatology Foundation – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant (1099 relationship)(Honoraria); HCW Biologics – Investigator(Grants/Research Funding); InflaRx – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Janssen Biotech – Investigator(Grants/Research Funding); Leo Pharma – Investigator(Grants/Research Funding); National Comprehensive Cancer Network – Speaker(Honoraria); Pfizer Inc. – Data Safety Monitoring Board(Fees); Protillion Biosciences – Consultant (1099 relationship)(Stock Options);
Jesse J Keller, MD, FAAD
Galderma USA – Speaker(Honoraria);
Kalyani Marathe, MD, MPH, FAAD
Guidepoint Global, LLC – Advisory Board(Fees); Leo Pharma – Advisory Board(Honoraria);
Robert Micheletti, MD, FAAD
Boehringer Ingelheim – Investigator(Grants/Research Funding); Cabaletta Bio – Investigator(Grants/Research Funding); Vertex Pharmaceuticals, Inc. – Consultant(Fees);
Helena Pasieka, MD, FAAD
No financial relationships exist with ineligible companies.